LONDON, Jan. 11, 2018 /PRNewswire/ -- Global Hypodermic Needles Market by Product Type {Safety Hypodermic Needles, by Type (Retractable Needles, Non-retractable Needles) and Safety Hypodermic Needles, by Mode of Activation (Active Needles and Passive Needles), Non-Safety Hypodermic Needles}, Application (Drug Delivery, Vaccination, and Blood Specimen Collection), End User (Hospitals, Diabetic Patients, Family Practices, Psychiatrics, and Others) - Global Opportunity Analysis and Industry Forecast, 2014-2022Download the full report: https://www.reportbuyer.com/product/4930884
Hypodermic needles are hollow, cylindrical needles with a puncture point at the pointed tip, which are attached to hypodermic syringes. These needles are used to inject solutions through subcutaneous, intravenous, and intramuscular modes for rapid uptake of substances (insulin, vaccines, and others) that are not readily absorbed in the body. These needles are also used to extract body fluids for diagnosis.Increase in incidence of needle stick injuries, implementation of stringent compliance for using safety needles, and surge in demand for injectable drugs & vaccines drive the market. In addition, rise in incidence of chronic and lifestyle diseases, especially diabetes supplement the market growth. However, availability of alternative modes of drug delivery, unawareness regarding safety syringes, and high cost of hypodermic needles hamper the market growth. Furthermore, the untapped emerging economies present lucrative opportunities for the market. The global hypodermic needles market accounted for $2,396 million in 2015, and is anticipated to reach $3,842 million by 2022, registering a CAGR of 6.9% from 2016 to 2022The global hypodermic needles market is segmented based on product type, applications, end user, and geography both in terms of both value and volume. Based on product type, the market is bifurcated into safety and non-safety hypodermic needles. The safety hypodermic needles segment is further classified based on type and mode of activation. Based on type, safety hypodermic needles are divided into retractable and non-retractable needles. Based on the mode of activation, safety hypodermic needles are classified into active and passive hypodermic needles. The safety hypodermic needle holds the largest market share, owing to the technological advancements (retractable & passive needles and others), prevention of needle-stick injuries and safety mechanisms embedded in these needles. Based on application, this market is categorized into drug delivery, vaccination, and blood specimen collection. The drug delivery application was the highest revenue contributor in 2015, while the vaccination segment is anticipated to grow at the highest rate. The growth for this segment is due to the high birth rates and awareness regarding vaccination throughout the world.Geographically, this market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the hypodermic needles market in 2015, and is expected to retain its dominance throughout the forecast period. This is primarily attributed to the higher buying power and stringent regulations that favor the utilization of hypodermic needles in this region. There is also increased awareness regarding the risk of cross infection (such as Hepatitis, HIV, and AIDS) and needle stick injuries in this region. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapidly developing economic conditions.Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global hypodermic needles market.KEY MARKET BENEFITSThe study provides an in-depth analysis of the global hypodermic needles market along with the current trends and future estimations to elucidate the imminent investment pockets.The report presents quantitative analysis of the market for the period of 2014-2022 to enable stakeholders to capitalize on the prevailing market opportunities.Extensive analysis of the market based on product type assists in understanding the trends in the industry.Key market players along with their strategies are thoroughly analyzed to understand the competitive outlook of the industry.KEY MARKET SEGMENTSBy Product TypeSafety Hypodermic Needles, by TypeRetractableNon-retractableSafety Hypodermic Needles, by Mode of ActivationActive Hypodermic NeedlesPassive Hypodermic NeedlesNon-Safety Hypodermic NeedlesBy ApplicationDrug DeliveryVaccinationBlood Specimen CollectionBy End UserHospitalsDiabetic PatientsFamily PracticesPsychiatricsOthersBy GeographyNorth AmericaU.S.CanadaMexicoEuropeGermanyFranceUKItalySpainRussiaRest of EuropeAsia-PacificJapanChinaAustraliaIndiaSouth KoreaTaiwanIndonesiaThailandRest of Asia-PacificLAMEABrazilTurkeyVenezuelaSaudi ArabiaSouth AfricaColombiaArgentinaRest of LAMEAKEY PLAYERS PROFILEDBecton, Dickinson and CompanyB. Braun Melsungen AGCatalent, Inc.Connecticut Hypodermics, Inc.EXELINT International Co.MedPro Safety Products, Inc.Medtronic plc,Retractable Technologies, Inc.Smiths Group plc,Terumo Medical Corporation.Other players in the value chain include (profiles not included in the report)Albert DavidDeRoyalHindustan Syringes & Medical Devices LimitedHi-Tech SyringesInternational Medsurg ConnectionMedline Industries, IncNipro Medical CorporationUnilife CorporationVita Needle CompanyVygonDownload the full report: https://www.reportbuyer.com/product/4930884
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith
Research Advisor at Reportbuyer.com Email: [email protected] Tel: +1 (646) 453 6293 Website: www.reportbuyer.com
Advertisement
View original content:http://www.prnewswire.com/news-releases/the-global-hypodermic-needles-market-accounted-for-2396-million-in-2015-and-is-anticipated-to-reach-3842-million-by-2022-registering-a-cagr-of-69-from-2016-to-2022-300581593.html
SOURCE ReportBuyer
